Huizhen Nie

Huizhen Nie


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 January 2022 in Oncogene
Verified
Journal Article
Closed access
PDF file
YZYi-Fan Zhang
Yi-Fan Zhang
QLQing Li
Qing Li
PHPei-Qi Huang
Pei-Qi Huang
TSTong Su
Tong Su
SJShu-Heng Jiang
Shu-Heng Jiang
HNHuizhen Nie
Huizhen Nie

26 February 2023 in Matrix Biology
Verified
Journal Article
Closed access
GTGuang-Ang Tian
Guang-Ang Tian
WXWen-Ting Xu
Wen-Ting Xu
Xueli ZhangXueli Zhang
Xueli Zhang
YZYaoqi Zhou
Yaoqi Zhou
YSYue Sun
Yue Sun
LYLin-Li Yao
Lin-Li Yao

1 January 2024 in Research
Verified
Journal Article
Open access
HPHong Pan
Hong Pan
YSYue Sun
Yue Sun
LQLi-Heng Qian
Li-Heng Qian
YLYing-Na Liao
Ying-Na Liao
YGYan-Zhi Gai
Yan-Zhi Gai
HNHuizhen Nie
Huizhen Nie
Ferroptosis, a nonapoptotic form of cell death, is an emerging potential therapeutic target for various diseases, including cancer. However, the role of ferroptosis in pancreatic cancer remains poorly understood. Pancreatic ductal adenocarcinoma (PDAC) is characterized by a poor prognosis and chemotherapy resistance, attributed to its high Kirsten rats arcomaviral oncogene homolog mutation rate and severe nutritional deficits resulting from a dense stroma. Several studies have linked rat sarcoma (RAS) mutations to ferroptosis, suggesting that inducing ferroptosis may be an effective strategy against oncogenic RAS-bearing tumors. We investigated the role of Family With Sequence Similarity 60 Member A (FAM60A) in this study, a protein closely associated with a poor prognosis and highly expressed in PDAC and tumor tissue from Kras G12D/+ ;Trp53 R172H/+ ; Pdx1-Cre mice, in regulating ferroptosis, tumor growth, and gemcitabine sensitivity in vitro and in vivo. Our results demonstrate that FAM60A regulates 3 essential metabolic enzymes, ACSL1/4 and GPX4, to protect PDAC cells from ferroptosis. Furthermore, we found that YY1 transcriptionally regulates FAM60A expression by promoting its transcription, and the Hippo-YY1 pathway is restricted in the low-amino-acid milieu in the context of nutrient deprivation, leading to downstream suppression of peroxisome proliferator-activated receptor and ACSL1/4 and activation of GPX4 pathways. Importantly, FAM60A knockdown sensitized PDAC cells to gemcitabine treatment. A new understanding of FAM60A transcriptional regulation pattern in PDAC and its dual function in ferroptosis reliever and chemotherapy resistance is provided by our study. Targeting FAM60A may therefore offer a promising therapeutic approach for PDAC by simultaneously addressing 2 major features of the disease (high RAS mutation rate and tumor microenvironment nutrient deficiency) and preventing tumor cell metabolic adaptation.

1 April 2019 in Chinese Clinical Oncology
Verified
Journal Article
Closed access
PDF file
YZYi-Fan Zhang
Yi-Fan Zhang
SJShu-Heng Jiang
Shu-Heng Jiang
LHLi-Peng Hu
Li-Peng Hu
PHPei-Qi Huang
Pei-Qi Huang
XWXu Wang
Xu Wang
ZZZhi-Gang Zhang
Zhi-Gang Zhang
Pancreatic ductal adenocarcinoma (PDAC) is one of the most dangerous cancers, and the overall 5-year survival rate is only 8%. The microenvironment of PDAC, which promotes tumorigenesis, disease development and metastasis, consists of fibroblasts, immune cells, pancreatic stellate cells (PaSCs), adipocytes and extracellular matrix (ECM). Because the microenvironment is a part of the tumor, it is also an important target for PDAC treatment. Several therapeutic regimens targeting PDAC microenvironment factors or cells have been investigated, but the treatment effects were poor. More research on the physiological and pathological mechanisms and clinical treatment of PDAC is necessary.

21 September 2023 in Land Degradation & Development
Verified
Journal Article
Closed access
CLChong Li
Chong Li
Zhao-hui JiaZhao-hui Jia
Zhao-hui Jia
YTYing Zhou Tang
Ying Zhou Tang
SZShuifeng Zhang
Shuifeng Zhang
TLTao Li
Tao Li
CMChristoph Müller
Christoph Müller

17 March 2025 in Apoptosis
Verified
Journal Article
Closed access
PDF file
LQLi-Heng Qian
Li-Heng Qian
KWKai-Ling Wen
Kai-Ling Wen
YGYing Guo
Ying Guo
YLYing-Na Liao
Ying-Na Liao
MLMing-Yue Li
Ming-Yue Li
HNHuizhen Nie
Huizhen Nie